Personal profile
Research Focus Areas Hanze University of Applied Sciences * (mandatory by Hanze)
- Entrepreneurship
- Healthy Ageing
Research Focus Areas Research Centre or Centre of Expertise * (mandatory by Hanze)
- Medical Diagnostics & Point of Care Testing
- Healthcare & Biotechnology
Publinova themes
- Economics and Management
- Law
- Other
- ICT and Media
- Nature and Agriculture
- Health
- Technology
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 03 Good Health and Well-being -
SDG 11 Sustainable Cities and Communities -
SDG 12 Responsible Consumption and Production -
SDG 13 Climate Action
Fingerprint
Dive into the research topics where Fin Milder is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies
Dijkhuizen, C. (First author), Korthuis, P., Aguado, C., Garcia-Román, S., Aguilar-Hernández, A., Drayer, L., De Looff, M., Milder, F., van der Wekken, A. & van den Berg, A., 13 Jun 2025. 2 p.Research output: Contribution to conference › Abstract › Academic
File98 Downloads (Pure) -
Molecular simulations explain the effects of the p.(L2026M+G2032R) double mutation in ROS1 on targeted TKI treatment
Dijkhuizen, C. (First author), Korthuis, P., Drayer, L., De Looff, M., Milder, F., van den Berg, A., van der Wekken, A. & Wassenaar, T., 26 Aug 2025, (Submitted). 1 p.Research output: Contribution to conference › Abstract › Academic
-
Repotrectinib resistance in a Ba/F3 SLC34A2-ROS1 cell line
Korthuis, P. (First author), Dijkhuizen, C., Drayer, L., Hiltermann, J., De Looff, M., Milder, F., van den Berg, A., van der Wekken, A. & Eijk, T., 18 Jun 2025, (Unpublished). 1 p.Research output: Contribution to conference › Poster › Academic
File65 Downloads (Pure) -
ROS1+ in vitro models: two new patient-derived NSCLC cell lines
Dijkhuizen, C., Korthuis, P., Aguado, C., Garcia-Román, S., Aguilar-Hernández, A., Drayer, L., Hiltermann, J., De Looff, M., Milder, F., van den Berg, A. & van der Wekken, A., 17 Jun 2025. 1 p.Research output: Contribution to conference › Poster › Academic
File107 Downloads (Pure) -
TKI sensitivity of ROS1+ lung cancer cell lines in 2D versus 3D culturing conditions
Dijkhuizen, C. (First author), Korthuis, P., Aguado, C., Garcia-Román, S., Aguilar-Hernández, A., Drayer, L., De Looff, M., Milder, F., van den Berg, A. & van der Wekken, A., 15 Jul 2025, (Accepted/In press). 2 p.Research output: Contribution to conference › Abstract › Academic
-
-
Lectorate Biomolecules & Health
Milder, F. (Speaker)
17 Apr 2025Activity: Talk or presentation › Oral presentation
-
Onderzoeksmiddag Instituut Life Science & Technology
Milder, F. (Speaker)
17 Apr 2025Activity: Talk or presentation › Oral presentation
-
Infectieziekten (en vaccines)
Milder, F. (Speaker)
23 Jun 2025Activity: Talk or presentation › Invited talk